Alignment Healthcare, Inc. (ALHC) Stock Forecast
ALHC analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.21 / 5 from 14 analysts
- Price target
- $13.31 average of analyst targets
- Upside to target
- +60.7% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $-0.04
- 52-week range
- $7.54 – $24.56
ALHC analyst ratings
14 analystsNumber of analysts at each rating.
ALHC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ALHC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.04 | $0.02 | $0.06 | $0.10 | −56.7% | 4 |
| Current fiscal year (2026) | $0.45 | $0.42 | $0.49 | $0.32 | +40.8% | 4 |
| Next fiscal year (2027) | $0.65 | $0.55 | $0.71 | $0.45 | +43.6% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ALHC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.31B | $1.31B | $1.32B | +32.1% | 11 |
| Current fiscal year (2026) | $5.22B | $5.20B | $5.25B | +32.1% | 12 |
| Next fiscal year (2027) | $6.51B | $6.38B | $6.72B | +24.7% | 12 |
ALHC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ALHC revenue: reported and forecast
ALHC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.14 | $0.06 | $0.06 | $0.06 | $0.04 | −68.5% | 0 up · 0 down |
| Current fiscal year (2026) | $0.47 | $0.49 | $0.49 | $0.49 | $0.45 | −4.7% | 0 up · 0 down |
| Next fiscal year (2027) | $0.72 | $0.75 | $0.75 | $0.75 | $0.65 | −10.0% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ALHC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ALHC beat in 9 of 12.
What analysts expect from ALHC
14 analysts cover Alignment Healthcare; their consensus rating is buy (4.21 on a 1–5 scale, where 5 is a strong buy). The average price target is $13.31, 60.7% above the latest close of $8.28. Analysts expect earnings of $0.45 per share for 2026, +40.8% from a year earlier. For 2027 the average estimate is $0.65 per share on revenue of $6.5 billion. Alignment Healthcare beat the EPS estimate in 9 of the last 12 quarters.
Related: ALHC income statement, ALHC key metrics, ALHC chart. See the ALHC stock overview for the latest quote and news.
ALHC forecast FAQ
What is Alignment Healthcare's price target?
The average analyst price target for Alignment Healthcare is $13.31, 60.7% above the latest close of $8.28.
Is Alignment Healthcare a buy, hold or sell?
Of 14 analysts covering Alignment Healthcare, 7 rate it a strong buy, 3 a buy, 4 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Alignment Healthcare's EPS forecast?
Analysts forecast $0.45 per share for 2026 (range $0.42 to $0.49); for 2027 the estimate is $0.65.
What is Alignment Healthcare's revenue forecast?
The average revenue estimate for 2026 is $5.2 billion, growth of 32.1%; for 2027 it is $6.5 billion.
When does Alignment Healthcare report earnings?
Alignment Healthcare is expected to report results for the quarter ending September 30, 2026 on October 29, 2026 after the market closes; the EPS estimate is $-0.04.
Does Alignment Healthcare usually beat earnings estimates?
Alignment Healthcare reported EPS at or above the analyst estimate in 9 of the last 12 quarters.